Thioether substituted imidazoquinolines - Patent US6664264(B2)

Filed: Dec 06, 2001

Published: Dec 16, 2003

Abstract

Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Applicants

3M INNOVATIVE PROPERTIES CO

Inventors

RADMER MATTHEW R
DELLARIA JOSEPH F
MERRILL BRYON A

Application Number

10013059

Priority Claims

US25421800

Family Members

US2002173655(A1) - Thioether substituted imidazoquinolines

US2003100764(A1) - Thioether substituted imidazoquinolines

US6664264(B2) - Thioether substituted imidazoquinolines

US6667312(B2) - Thioether substituted imidazoquinolines

US2004102471(A1) - Thioether substituted imidazoquinolines

US6921826(B2) - Thioether substituted imidazoquinolines

Classification Codes

A61P37/02, C07D471/04, A61P37/00, C07D471/00, A61P31/12, A61P31/02, A61P31/00